Ondansetron HCL 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FR3BU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,134
Award facts
- Contract value 100% obligated
- $25,134.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ondansetron HCl 4 mg tablets (30-count packaging) with a ceiling value of $25,134.02. This firm fixed-price delivery order, which is not set-aside, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The product will be performed and delivered from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025.
As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal military and healthcare procurement through the DLA Medical Supply Chain. Ondansetron, an antiemetic medication commonly used to prevent nausea and vomiting in medical settings, represents one of numerous pharmaceutical products the company supplies to support Defense Health Agency operations and other government healthcare systems. This delivery order exemplifies the routine, competitive pharmaceutical procurement that occurs under AmerisourceBergen's comprehensive prime vendor agreement, which enables flexible medical supply fulfillment across multiple therapeutic domains for military and federal healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB25FR3BU?
SPE2DB25FR3BU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FR3BU worth?
The government has obligated $25,134 on SPE2DB25FR3BU.
Is contract SPE2DB25FR3BU an order under another contract?
Yes. SPE2DB25FR3BU is a delivery order under SPE2DB22D2218, an indefinite delivery contract.
Was contract SPE2DB25FR3BU competed?
The extent of competition for SPE2DB25FR3BU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award